Asia-Pacific
A fresh wave of deals highlights why investors favour IP firms and why independent outfits may soon have to rethink their strategy
Peter O’Sullivan, a professional services executive, says he is looking forward to helping Pearce IP become the leading life sciences firm in Australia and New Zealand
Ranjna Mehta-Dutt, who moved to Chadha & Chadha after 25 years at Remfry & Sagar, says the firm plans to expand its life sciences practice through targeted recruitment and dedicated teams for bigger clients
Law firms across the world are seemingly united in their reluctance to give juniors a chance, which shouldn’t be the case
Sponsored
Sponsored
-
Sponsored by Griffith HackDespite being a market of only 26 million people, Australia possesses a world-class healthcare system and well regarded scientific community. This is most recently demonstrated through the participation of Australian scientists in the race to successfully manufacture a COVID-19 vaccine, and by the low infection death rates from the current pandemic in Australia. -
Sponsored by Liu, Shen & AssociatesThe global COVID-19 pandemic is affecting the world in various ways. One of the lessons we have learnt from this traumatic period is that while people always tried to find value in cooperation rather than in rivalry, cooperation could be more fragile than expected, especially in a multilateral scenario.
-
Sponsored by Remfry & SagarIn the second article from an exclusive series on the automotive industry, Pankaj Soni of Remfry & Sagar discusses patent protection in India
-
Sponsored by AJ ParkWhat happens when a third party files a trademark application for your unregistered trademark?
-
Sponsored by Remfry & SagarIn the first article from an exclusive series on the automotive industry, Gaurav Mukerjee and Raghav Paul of Remfry & Sagar discuss counterfeits in India
-
Sponsored by AJ ParkA registration regime for foodstuff geographical indications (GIs) may soon be on the menu for New Zealand. If this happens, Prosciutto di Parma, Kalamata Olives and Feta will likely be struck off the menu, along with around 2,200 other product names.
